Fellowship · Houston, TX
Sponsored by Baylor College of Medicine
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
The New England journal of medicine · 2021 · 967 citations · Lavannya Pandit
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis.
Annual review of pathology · 2022 · 683 citations · Benjamin Moss, Ivan Rosas
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.
The New England journal of medicine · 2023 · 433 citations · Nicola Hanania
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.
The New England journal of medicine · 2021 · 798 citations · Ivan Rosas
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation.
The New England journal of medicine · 2024 · 246 citations · Nicola Hanania
Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement.
American journal of respiratory and critical care medicine · 2025 · 85 citations · Ivan Rosas
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.
The Lancet. Respiratory medicine · 2023 · 186 citations · Ivan Rosas
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials.
The Lancet. Respiratory medicine · 2025 · 80 citations · Nicola Hanania